Metraipolis › archive › dc_62bd729addde

In Vivo Model of Short-Term Efficacy and Favorable Safety of Botulinum Toxin Type E Compared with Type A — Europe PMC PMID:42188633

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42188633
DOI
10.3390/toxins18050231
License (as archived)
solo-consultazione
Archived
2026-11-02T06:24:43.921Z
SHA-256 of the archived text
5666f99eb16d86927f7ce3ee4892bb1ad922165bdb74919a7ca6182bb6b55969
Stable URL of this page
https://metraipolis.com/documento/dc_62bd729addde

How to cite

In Vivo Model of Short-Term Efficacy and Favorable Safety of Botulinum Toxin Type E Compared with Type A — Europe PMC PMID:42188633 — Europe PMC (en), https://europepmc.org/article/MED/42188633 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_62bd729addde (Metraipolis archive dc_62bd729addde, sha256 5666f99eb16d86927f7ce3ee4892bb1ad922165bdb74919a7ca6182bb6b55969)
BibTeX
@misc{dc62bd729addde,
  title = {In Vivo Model of Short-Term Efficacy and Favorable Safety of Botulinum Toxin Type E Compared with Type A — Europe PMC PMID:42188633},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42188633},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_62bd729addde; sha256 5666f99eb16d86927f7ce3ee4892bb1ad922165bdb74919a7ca6182bb6b55969},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42188633. Agents can read the archived copy with the MCP tool read_document.